Cargando…
Study of the Molecular Dynamics Stability in the Inhibitory Interaction of Tenofovir Disoproxil Fumarate against CTLA-4 in Chronic Hepatitis B Patients
BACKGROUND: Tenofovir disoproxil fumarate (TDF) is a first-line nucleotide analog (NA) drug for hepatitis B therapy. Long-term NA therapy increases peripheral T cell levels to enhance antiviral response, while CTLA-4 inhibits the activation. OBJECTIVE: This study analyzed the interaction between TDF...
Autores principales: | Darmadi, Darmadi, Lindarto, Dharma, Siregar, Jelita, Widyawati, Tri, Rusda, Muhammad, Amin, Mustafa Mahmud, Yusuf, Fauzi, Eyanoer, Putri Chairani, Lubis, Masrul, Rey, Imelda |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Academy of Medical Sciences of Bosnia and Herzegovina
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10495148/ https://www.ncbi.nlm.nih.gov/pubmed/37700917 http://dx.doi.org/10.5455/medarh.2023.77.227-230 |
Ejemplares similares
-
Factors affecting HBV DNA suppression in chronic hepatitis B patients treated with tenofovir disoproxil fumarate
por: Darmadi, Darmadi, et al.
Publicado: (2023) -
Association Between Serum Cytotoxic T Lymphocyte Antigen (CTLA)-4 Level and Disease Progression in Patients With Chronic Hepatitis B
por: Darmadi, Darmadi, et al.
Publicado: (2023) -
Association Between Serum Midkine Level and Gastric Precancerous Lesion in Patients with Gastritis
por: Siregar, Jelita, et al.
Publicado: (2022) -
Comparative pharmacokinetics between tenofovir disoproxil phosphate and tenofovir disoproxil fumarate in healthy subjects
por: Lee, Sangmi, et al.
Publicado: (2021) -
Comparative Meta-Analysis of Tenofovir Disoproxil Fumarate versus Emtricitabine and Tenofovir Disoproxil Fumarate as Treatments for Patients with Chronic Hepatitis B
por: Cui, Guangying, et al.
Publicado: (2015)